Experimental basis for lidocaine therapy in cochlear disorders

E. Laurikainen, Alfred Nuttall, J. M. Miller, W. S. Quirk, E. Virolainen

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

In order to further our basic understanding of the effects of lidocaine hydrochloride in the inner ear, cochlear potentials and blood flow (CBF) were assessed after intravenous (i.v.), anterior inferior cerebellar artery (AICA), and local round window (RW) lidocaine administrations in guinea pigs and rats. Lidocaine RW applications produced a dose dependent decrease in compound action potentials (CAP) and cochlear microphonics (CM). The sensitivity changes were more pronounced at high frequencies. These findings suggest that lidocaine has specific pharmacological action in the inner ear other than simple anesthesia of the auditory nerve. The basal turn endocohlear potentials (EP) were not altered by topical lidocaine, implicating altered organ of Corti function following local application of lidocaine. RW applications of lidocaine had no effect on CBF or systemic blood pressure (BP). I.v. infusions caused substantial reductions in BP. In the case of systemic infusions the percent changes in CBF were equal to and accountable by the BP changes. The microinfu-sions (50 mg/ml, 100 nl/min) through AICA produced a 30% long lasting increase in CBF. However, neither systemic lidocaine nor AICA infusions had an effect on CAP or CM. These findings indicate that systemically given lidocaine may not cross the blood-cochlear barrier and that the cochlear electrophysiological effects due to lidocaine when given locally are partly mediated by direct influence on cochlear hair cell function; they also suggest that lidocaine-induced interference with active ion transport in the lateral wall or an influence on CBF are not contributing factors.

Original languageEnglish (US)
Pages (from-to)800-809
Number of pages10
JournalActa Oto-Laryngologica
Volume112
Issue number2
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Cochlea
Lidocaine
Therapeutics
Arteries
Inner Ear
Blood Pressure
Action Potentials
Auditory Hair Cells
Organ of Corti
Cochlear Nerve
Ion Transport
Guinea Pigs
Anesthesia
Pharmacology

Keywords

  • Cochlear blood flow
  • Cochlear blood-barrier
  • Endocochlear potential
  • Evoked cochlear potentials
  • Hair cells
  • Lidocaine hydrochloride
  • Meniere's disease
  • Ouabain

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Laurikainen, E., Nuttall, A., Miller, J. M., Quirk, W. S., & Virolainen, E. (1992). Experimental basis for lidocaine therapy in cochlear disorders. Acta Oto-Laryngologica, 112(2), 800-809. https://doi.org/10.3109/00016489209137477

Experimental basis for lidocaine therapy in cochlear disorders. / Laurikainen, E.; Nuttall, Alfred; Miller, J. M.; Quirk, W. S.; Virolainen, E.

In: Acta Oto-Laryngologica, Vol. 112, No. 2, 1992, p. 800-809.

Research output: Contribution to journalArticle

Laurikainen, E, Nuttall, A, Miller, JM, Quirk, WS & Virolainen, E 1992, 'Experimental basis for lidocaine therapy in cochlear disorders', Acta Oto-Laryngologica, vol. 112, no. 2, pp. 800-809. https://doi.org/10.3109/00016489209137477
Laurikainen, E. ; Nuttall, Alfred ; Miller, J. M. ; Quirk, W. S. ; Virolainen, E. / Experimental basis for lidocaine therapy in cochlear disorders. In: Acta Oto-Laryngologica. 1992 ; Vol. 112, No. 2. pp. 800-809.
@article{e50f0ddef43c444cb7d002c8d90aae48,
title = "Experimental basis for lidocaine therapy in cochlear disorders",
abstract = "In order to further our basic understanding of the effects of lidocaine hydrochloride in the inner ear, cochlear potentials and blood flow (CBF) were assessed after intravenous (i.v.), anterior inferior cerebellar artery (AICA), and local round window (RW) lidocaine administrations in guinea pigs and rats. Lidocaine RW applications produced a dose dependent decrease in compound action potentials (CAP) and cochlear microphonics (CM). The sensitivity changes were more pronounced at high frequencies. These findings suggest that lidocaine has specific pharmacological action in the inner ear other than simple anesthesia of the auditory nerve. The basal turn endocohlear potentials (EP) were not altered by topical lidocaine, implicating altered organ of Corti function following local application of lidocaine. RW applications of lidocaine had no effect on CBF or systemic blood pressure (BP). I.v. infusions caused substantial reductions in BP. In the case of systemic infusions the percent changes in CBF were equal to and accountable by the BP changes. The microinfu-sions (50 mg/ml, 100 nl/min) through AICA produced a 30{\%} long lasting increase in CBF. However, neither systemic lidocaine nor AICA infusions had an effect on CAP or CM. These findings indicate that systemically given lidocaine may not cross the blood-cochlear barrier and that the cochlear electrophysiological effects due to lidocaine when given locally are partly mediated by direct influence on cochlear hair cell function; they also suggest that lidocaine-induced interference with active ion transport in the lateral wall or an influence on CBF are not contributing factors.",
keywords = "Cochlear blood flow, Cochlear blood-barrier, Endocochlear potential, Evoked cochlear potentials, Hair cells, Lidocaine hydrochloride, Meniere's disease, Ouabain",
author = "E. Laurikainen and Alfred Nuttall and Miller, {J. M.} and Quirk, {W. S.} and E. Virolainen",
year = "1992",
doi = "10.3109/00016489209137477",
language = "English (US)",
volume = "112",
pages = "800--809",
journal = "Acta Oto-Laryngologica",
issn = "0001-6489",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Experimental basis for lidocaine therapy in cochlear disorders

AU - Laurikainen, E.

AU - Nuttall, Alfred

AU - Miller, J. M.

AU - Quirk, W. S.

AU - Virolainen, E.

PY - 1992

Y1 - 1992

N2 - In order to further our basic understanding of the effects of lidocaine hydrochloride in the inner ear, cochlear potentials and blood flow (CBF) were assessed after intravenous (i.v.), anterior inferior cerebellar artery (AICA), and local round window (RW) lidocaine administrations in guinea pigs and rats. Lidocaine RW applications produced a dose dependent decrease in compound action potentials (CAP) and cochlear microphonics (CM). The sensitivity changes were more pronounced at high frequencies. These findings suggest that lidocaine has specific pharmacological action in the inner ear other than simple anesthesia of the auditory nerve. The basal turn endocohlear potentials (EP) were not altered by topical lidocaine, implicating altered organ of Corti function following local application of lidocaine. RW applications of lidocaine had no effect on CBF or systemic blood pressure (BP). I.v. infusions caused substantial reductions in BP. In the case of systemic infusions the percent changes in CBF were equal to and accountable by the BP changes. The microinfu-sions (50 mg/ml, 100 nl/min) through AICA produced a 30% long lasting increase in CBF. However, neither systemic lidocaine nor AICA infusions had an effect on CAP or CM. These findings indicate that systemically given lidocaine may not cross the blood-cochlear barrier and that the cochlear electrophysiological effects due to lidocaine when given locally are partly mediated by direct influence on cochlear hair cell function; they also suggest that lidocaine-induced interference with active ion transport in the lateral wall or an influence on CBF are not contributing factors.

AB - In order to further our basic understanding of the effects of lidocaine hydrochloride in the inner ear, cochlear potentials and blood flow (CBF) were assessed after intravenous (i.v.), anterior inferior cerebellar artery (AICA), and local round window (RW) lidocaine administrations in guinea pigs and rats. Lidocaine RW applications produced a dose dependent decrease in compound action potentials (CAP) and cochlear microphonics (CM). The sensitivity changes were more pronounced at high frequencies. These findings suggest that lidocaine has specific pharmacological action in the inner ear other than simple anesthesia of the auditory nerve. The basal turn endocohlear potentials (EP) were not altered by topical lidocaine, implicating altered organ of Corti function following local application of lidocaine. RW applications of lidocaine had no effect on CBF or systemic blood pressure (BP). I.v. infusions caused substantial reductions in BP. In the case of systemic infusions the percent changes in CBF were equal to and accountable by the BP changes. The microinfu-sions (50 mg/ml, 100 nl/min) through AICA produced a 30% long lasting increase in CBF. However, neither systemic lidocaine nor AICA infusions had an effect on CAP or CM. These findings indicate that systemically given lidocaine may not cross the blood-cochlear barrier and that the cochlear electrophysiological effects due to lidocaine when given locally are partly mediated by direct influence on cochlear hair cell function; they also suggest that lidocaine-induced interference with active ion transport in the lateral wall or an influence on CBF are not contributing factors.

KW - Cochlear blood flow

KW - Cochlear blood-barrier

KW - Endocochlear potential

KW - Evoked cochlear potentials

KW - Hair cells

KW - Lidocaine hydrochloride

KW - Meniere's disease

KW - Ouabain

UR - http://www.scopus.com/inward/record.url?scp=0026732786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026732786&partnerID=8YFLogxK

U2 - 10.3109/00016489209137477

DO - 10.3109/00016489209137477

M3 - Article

VL - 112

SP - 800

EP - 809

JO - Acta Oto-Laryngologica

JF - Acta Oto-Laryngologica

SN - 0001-6489

IS - 2

ER -